Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Tachykinin NK2 antagonists in early development at Menarini

Jan. 12, 2005

Kalypsys patent covers novel PPAR modulators for obesity, diabetes, etc.

Jan. 12, 2005

Akt inhibitors prepared and tested at Lilly

Jan. 12, 2005

Ono discloses a series of CCR5 receptor antagonists

Jan. 12, 2005

Thiazolidinedione derivatives claimed by Incyte

Jan. 12, 2005

Elan/Pfizer collaboration produces novel BACE inhibitors

Jan. 11, 2005

Phospholipase inhibitors prepared and tested at Lilly

Jan. 11, 2005

Merck patent discloses synthesis of novel chemokine CCR2 receptor modulators

Jan. 11, 2005

CRF-1 receptor antagonists in early development at Pfizer

Jan. 11, 2005

Macrolide antiinflammatory agents patented by Pliva

Jan. 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...